217 related articles for article (PubMed ID: 19459168)
1. Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study.
Horsdal HT; Johnsen SP; Søndergaard F; Jacobsen J; Thomsen RW; Schmitz O; Sørensen HT; Rungby J
Diabetes Metab Res Rev; 2009 Sep; 25(6):515-22. PubMed ID: 19459168
[TBL] [Abstract][Full Text] [Related]
2. Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.
Horsdal HT; Mehnert F; Rungby J; Johnsen SP
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):717-25. PubMed ID: 21536457
[TBL] [Abstract][Full Text] [Related]
3. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
4. Coronary heart disease outcomes in patients receiving antidiabetic agents.
McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
[TBL] [Abstract][Full Text] [Related]
5. Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study.
Horsdal HT; Johnsen SP; Søndergaard F; Rungby J
Diabetologia; 2008 Apr; 51(4):567-74. PubMed ID: 18283428
[TBL] [Abstract][Full Text] [Related]
6. Coronary heart disease outcomes in patients receiving antidiabetic agents in the PharMetrics database 2000-2007.
Walker AM; Koro CE; Landon J
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):760-8. PubMed ID: 18383443
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
Yap YG; Duong T; Bland JM; Malik M; Torp-Pederson C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
J Hypertens; 2007 Feb; 25(2):307-13. PubMed ID: 17211237
[TBL] [Abstract][Full Text] [Related]
8. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
[TBL] [Abstract][Full Text] [Related]
9. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
10. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
Schramm TK; Gislason GH; Vaag A; Rasmussen JN; Folke F; Hansen ML; Fosbøl EL; Køber L; Norgaard ML; Madsen M; Hansen PR; Torp-Pedersen C
Eur Heart J; 2011 Aug; 32(15):1900-8. PubMed ID: 21471135
[TBL] [Abstract][Full Text] [Related]
11. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
[TBL] [Abstract][Full Text] [Related]
12. Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension.
Jonas M; Reicher-Reiss H; Boyko V; Behar S; Grossman E
J Hum Hypertens; 2003 Oct; 17(10):665-70. PubMed ID: 14504623
[TBL] [Abstract][Full Text] [Related]
13. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
[TBL] [Abstract][Full Text] [Related]
14. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
15. Role of previous treatment with sulfonylureas in diabetic patients with acute myocardial infarction: results from a nationwide French registry.
Danchin N; Charpentier G; Ledru F; Vaur L; Guéret P; Hanania G; Blanchard D; Lablanche JM; Genès N; Cambou JP
Diabetes Metab Res Rev; 2005; 21(2):143-9. PubMed ID: 15386810
[TBL] [Abstract][Full Text] [Related]
16. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP).
Leander K; Wiman B; Hallqvist J; Andersson T; Ahlbom A; de Faire U
Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):532-7. PubMed ID: 17667644
[TBL] [Abstract][Full Text] [Related]
17. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
[TBL] [Abstract][Full Text] [Related]
18. Impact of metabolic syndrome on future cardiovascular events in patients with first acute myocardial infarction.
Selcuk H; Temizhan A; Selcuk MT; Sen T; Maden O; Tekeli S; Sasmaz A
Coron Artery Dis; 2009 Sep; 20(6):370-5. PubMed ID: 19609207
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study.
Horsdal HT; Søndergaard F; Johnsen SP; Rungby J
Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):331-7. PubMed ID: 21442682
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
Levantesi G; Macchia A; Marfisi R; Franzosi MG; Maggioni AP; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
J Am Coll Cardiol; 2005 Jul; 46(2):277-83. PubMed ID: 16022955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
